| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/25/2007 | CN1953750A Novel uses for proton pump inhibitors |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951917A Pyridinone derivatives for treatment of atherosclerosis |
| 04/25/2007 | CN1951899A Aspirin-triggered lipid mediators |
| 04/25/2007 | CN1951484A Oil for treating wounds |
| 04/25/2007 | CN1951483A Hybrid safflower oil and preparation method thereof |
| 04/25/2007 | CN1951468A Medicament for treating protrusion of intervertebral disc and preparation method thereof |
| 04/25/2007 | CN1951467A Compound Chinese medicinal preparation for treating osteoporosis |
| 04/25/2007 | CN1951465A Medicament for treating bony spur |
| 04/25/2007 | CN1951462A Testing process for 'Gu Jin Wan' capsule |
| 04/25/2007 | CN1951459A Medicament for matching with holographic fire burning therapy in acupoints and preparation method thereof |
| 04/25/2007 | CN1951455A Spine applied ointment with inflammation-diminishing and pain-relieving functions |
| 04/25/2007 | CN1951452A A medicament for treating bone fracture and preparation method thereof |
| 04/25/2007 | CN1951429A Preparation process of corydalis rhizome extract and novel usage thereof |
| 04/25/2007 | CN1951428A Chinese medicinal composition for treating traumatic diseases, its preparation method and quality control method |
| 04/25/2007 | CN1951397A Physiological balanced nutrient with physiological balanced calcium |
| 04/25/2007 | CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/25/2007 | CN1951360A Complex salt crystal used for body surface physical therapy and preparation method thereof |
| 04/25/2007 | CN1312285C Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1312167C Epimedium extract and its production method |
| 04/25/2007 | CN1312147C Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 04/25/2007 | CN1312125C Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 04/25/2007 | CN1312120C Adamantane derivatives |
| 04/25/2007 | CN1312116C Calcium acceptor active compound |
| 04/25/2007 | CN1311843C Chinese herbal medicinal preparation for treating hyperosteogeny |
| 04/25/2007 | CN1311835C Pharmaceutical parenteral composition containing biphosphonate |
| 04/25/2007 | CN1311829C Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 04/24/2007 | US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2007 | US7208594 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds, |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208498 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/24/2007 | US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 04/24/2007 | US7208469 Administering adrenomedullin for stimulate chondrocyte proliferation; treatment of cartilage defects, bone disorders, growth disorders; biodrugs |
| 04/24/2007 | US7208466 Treating pain or inflammation; inhibiting C-fibre neuron activity; hemagglutinins conjugated with protein |
| 04/24/2007 | US7208279 Method for identifying inhibitors of G protein coupled receptor signaling |
| 04/24/2007 | US7208166 Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology |
| 04/24/2007 | CA2403902C Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/24/2007 | CA2353528C Use of ibandronate for promoting osseointegration of endoprostheses |
| 04/24/2007 | CA2303763C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/24/2007 | CA2159776C Imidobisphosphoric acids, process for their preparation, and use thereof |
| 04/19/2007 | WO2007044375A2 Pth formulations and methods of use |
| 04/19/2007 | WO2007043900A1 Use of lactoferrin fragments and hydrolysates |
| 04/19/2007 | WO2007043810A1 Compositions comprising the extract of roasted licorice for preventing and treating bone diseases |
| 04/19/2007 | WO2007043629A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | WO2007043581A1 Thienopyridine-2-carboxamide derivative |
| 04/19/2007 | WO2007043457A1 Triarylcarboxylic acid derivative |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007017050A3 Method for isolating stem cells and stem cells derived from a pad-like tissue of teeth |
| 04/19/2007 | WO2007016285A3 M-csf specific monoclonal antibody and uses thereof |
| 04/19/2007 | WO2006077471A3 Combining therapies targeting multiple toll-like receptors and use thereof |
| 04/19/2007 | WO2006012779A8 Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical |
| 04/19/2007 | US20070088163 Modulators of calcitonin and amylin activity |
| 04/19/2007 | US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/19/2007 | US20070088068 E-series of prostaglandin (EP) receptors; reducing [4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetate to form [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
| 04/19/2007 | US20070088008 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3 |
| 04/19/2007 | US20070087963 Synthesis of cyclosporin analogs |
| 04/19/2007 | US20070087064 Composition for preventing and treating climacteric symptoms comprising the extract of sophorae fructus |
| 04/19/2007 | US20070086993 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 04/19/2007 | CA2627623A1 Methods for inhibiting protein kinases |
| 04/19/2007 | CA2625436A1 Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications |
| 04/19/2007 | CA2623563A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | CA2621038A1 Triarylcarboxylic acid derivative |
| 04/18/2007 | EP1773837A2 Pyrrolotriazine kinase inhibitors |
| 04/18/2007 | EP1773836A1 Pyrrolopyrimidine derivatives useful in cancer treatment |
| 04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 04/18/2007 | EP1773768A2 Pyrrole derivatives as pharmaceutical agents |
| 04/18/2007 | EP1773417A1 Methods and crosslinked polymer compositions for cartilage repair |
| 04/18/2007 | EP1773364A1 Nutritional compositions and methods for treating or preventing osteoporosis |
| 04/18/2007 | EP1773340A2 Pharmaceutical composition of (+)-erythro-mefloquine and its use in the treatment of an inflammatory condition |
| 04/18/2007 | EP1773335A2 Nanoparticle dispersion containing lactam compound |
| 04/18/2007 | EP1773332A1 Pharmaceutical composition for the treatment of bone fracture |
| 04/18/2007 | EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/18/2007 | EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 04/18/2007 | EP1436257B1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 04/18/2007 | EP1435976B1 Pharmaceutical composition comprising chito-oligomers |
| 04/18/2007 | EP1429817B1 Porous ceramic composite bone grafts |
| 04/18/2007 | EP1416887A4 Cartilage repair and regeneration device and method |
| 04/18/2007 | EP1416886A4 Cartilage repair and regeneration scaffold and method |
| 04/18/2007 | EP1416866A4 Devices form naturally occurring biologically derived |
| 04/18/2007 | EP1411970B1 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/18/2007 | EP1394161B1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 04/18/2007 | EP1354590B1 Glucosamine or mannosamine in combination with trehalose against articular failure |
| 04/18/2007 | EP1352063B1 Receptor nucleic acids and polypeptides |
| 04/18/2007 | EP1305030B1 Use of 2-alpha-methyl-19-nor-20(s)-1-alpha,25-dihydroxyvitamin d3 in bone replacement |
| 04/18/2007 | EP1240161B1 Thienylalanine derivatives as inhibitors of cell adhesion |
| 04/18/2007 | EP1192261B1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 04/18/2007 | CN1950389A Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 04/18/2007 | CN1950372A 咪唑并吡啶化合物 Imidazopyridine compound |
| 04/18/2007 | CN1950103A Methods for preventing or treating bone disorders |
| 04/18/2007 | CN1950102A Modulation of cartilage homeostasis |
| 04/18/2007 | CN1948343A Tetravalence single chain antibody of p53 tetra polymerized structure domain |
| 04/18/2007 | CN1947785A Medicine for treating bone fracture |
| 04/18/2007 | CN1947775A Medicine for treating hyperosteogeny |